H
Hospital Angeles Chihuahua | Clinical Research Unit
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Etrasimod
Ocrelizumab
Ataluren
Zanubrutinib
Viltolarsen
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 7 total trials
This is a Phase IIIb, single-arm, multicenter, OLE study. Participants receiving ocrelizumab as an investigational medicinal product (IMP) in a Roche...
Active, not recruiting
Multiple Sclerosis
Drug: Ocrelizumab
This study will evaluate the efficacy and safety of ocrelizumab ( Ocrevus®) compared with placebo in participants with primary progressive multiple s...
Enrolling
Multiple Sclerosis, Primary Progressive
Drug: Ocrelizumab
Drug: Placebo
The primary objectives of this study are: In Part 1 to evaluate the efficacy of zanubrutinib as measured by proteinuria reduction, and in Part 2 to e...
Enrolling
Primary Membranous Nephropathy
Drug: Tacrolimus
Drug: Zanubrutinib
Trial sponsors
A
N
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems